BAVENCIO CONCENTRATE FOR SOLUTION FOR INFUSION 200MG/10ML
MERCK PTE. LTD
Date of Approval
Bavencio is indicated for the first-line maintenance treatment of patients with locally advanced or metastatic urothelial carcinoma (UC) whose disease has not progressed with first-line platinum-based induction chemotherapy.
New Drug Indication Approvals